ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)
Japan flag Japan · Delayed Price · Currency is JPY
2,403.00
-30.00 (-1.23%)
Feb 13, 2026, 3:30 PM JST

TYO:4886 Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
5,68910,60313,73814,50512,10310,514
Short-Term Investments
8955553,5003,4005,000-
Cash & Short-Term Investments
6,58411,15817,23817,90517,10310,514
Cash Growth
-35.23%-35.27%-3.72%4.69%62.67%44.15%
Receivables
20,10415,09015,57915,21714,48213,153
Inventory
29,62226,33320,40217,68715,06014,372
Other Current Assets
4,3775,4662,9242,9502,9121,893
Total Current Assets
60,68758,04756,14353,75949,55739,932
Property, Plant & Equipment
19,07518,70911,26310,79610,93612,675
Long-Term Investments
19,56814,47217,76516,40014,24414,568
Goodwill
2,2524,361----
Other Intangible Assets
6,5712,6322,8774,4656,18311,893
Long-Term Deferred Tax Assets
1,7692,3122,6961,7172,3763,513
Other Long-Term Assets
2,77711111
Total Assets
112,699100,53490,74587,13883,29782,582
Accounts Payable
9,5339,1467,3555,8606,8416,455
Accrued Expenses
-1,2831,2251,1661,1881,151
Short-Term Debt
5,0602,521300300300350
Current Portion of Long-Term Debt
-1,9404,6803,1381,4232,298
Current Income Taxes Payable
-6,3678,6904,9474,8675,426
Other Current Liabilities
10,6801,6221,7182,2391,3921,057
Total Current Liabilities
25,27322,87923,96817,65016,01116,737
Long-Term Debt
8,6576,4414,5059,18512,32313,747
Pension & Post-Retirement Benefits
-206-5,4335,7306,419
Other Long-Term Liabilities
4,0281,8133433373411,169
Total Liabilities
37,95831,33928,81632,60534,40538,072
Common Stock
1,1971,1971,1971,1971,1971,197
Additional Paid-In Capital
31-1,8481,8471,867928
Retained Earnings
61,83259,54556,37249,61945,83341,790
Treasury Stock
-658-704-3,287-3,350-3,479-2,139
Comprehensive Income & Other
6,3345,2725,7995,2203,4742,734
Total Common Equity
68,73665,31061,92954,53348,89244,510
Minority Interest
6,0053,885----
Shareholders' Equity
74,74169,19561,92954,53348,89244,510
Total Liabilities & Equity
112,699100,53490,74587,13883,29782,582
Total Debt
13,71710,9029,48512,62314,04616,395
Net Cash (Debt)
-7,1332567,7535,2823,057-5,881
Net Cash Growth
--96.70%46.78%72.78%--
Net Cash Per Share
-251.209.03273.83187.05107.75-207.42
Filing Date Shares Outstanding
28.428.3628.3328.2928.1828.37
Total Common Shares Outstanding
28.428.3628.3328.2928.1828.37
Working Capital
35,41435,16832,17536,10933,54623,195
Book Value Per Share
2420.612302.592186.051927.971734.751568.87
Tangible Book Value
59,91358,31759,05250,06842,70932,617
Tangible Book Value Per Share
2109.902056.042084.491770.121515.371149.67
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.